Skip to Main Content

Wound Healing

Animal-origin-free proteins for every step of Wound Healing manufacturing.

From source tissue to final storage, recombinant albumin, transferrin, lactoferrin, and insulin-transferrin supplements replace serum and plasma-derived albumin and lower variability across skin and stromal cell cultures.

Where InVitria proteins fit in Wound Healing Manufacturing

Cell-based wound therapies depend on protein at every step: to protect keratinocytes, fibroblasts and stromal cells through isolation and washing, to support expansion and tissue formation, and to stabilize the finished product. Fetal bovine serum, bovine serum albumin and plasma-derived albumin bring variability, animal-derived material and adventitious-agent risk into a product applied to the wound. Defined, animal-origin-free recombinant proteins supply the same functions,
step by step.

Where our products fit

The Wound Healing workflow, step by step.

Starting Material & Cell Source

Procure the source material, a skin biopsy or marrow or adipose harvest, for the cells used in wound repair, with defined, animal-origin-free albumin.

Overview

Starting material and cell source is the first step in cell-based wound healing therapy. The cells used to repair skin are most often keratinocytes and fibroblasts isolated from a skin biopsy, or mesenchymal stromal cells from bone marrow or adipose tissue; iPSC-derived skin cells are an emerging allogeneic source. The starting material is procured from the patient or a donor.

The biopsy or harvested tissue is collected and transported to the manufacturing site before the cells are isolated. Handling, time, and temperature between collection and processing affect cell viability and the yield of usable cells.

Protecting the cells during this early window supports recovery and a consistent starting point, and a defined, animal-origin-free stabilizing protein avoids introducing serum- or animal-derived material at the start.

Functions

Starting Material Stabilization

Wound therapy cells are sourced from a skin biopsy or a marrow or adipose harvest, and the interval between collection and processing exposes the tissue and its cells to temperature shifts, handling, and surface contact. Cell viability at this stage affects the yield recovered for culture. A stabilizing protein in the transport or hold solution supports cell health before isolation begins.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum or plasma-derived albumin in tissue transport and hold solutions.

Cell Preparation

Isolate the keratinocytes, fibroblasts, or stromal cells from the source tissue and prepare them for culture, with defined, animal-origin-free albumin.

Overview

Cell preparation isolates the cells from the source tissue and readies them for expansion. A skin biopsy is enzymatically separated into epidermis and dermis to release keratinocytes and fibroblasts; marrow or adipose tissue is processed to isolate stromal cells. The isolated cells are washed and placed into culture.

Isolation exposes cells to enzymatic digestion, separation, and washing. Albumin is commonly included in isolation and wash solutions to protect cells and support viability as the culture establishes.

A defined, animal-origin-free recombinant albumin protects cells through isolation and preparation while keeping the workflow free of serum-derived material.

Functions

Cell Protection & Stabilization

During preparation, cells are released from the source tissue by enzymatic digestion and separation, then washed, which exposes them to proteolytic and handling stress. Albumin supports viability by transporting fatty acids and binding reactive species, buffering cells against handling and oxidative stress and helping quench residual enzyme as the cells move into culture.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum or bovine serum albumin (BSA) in isolation and wash solutions.

Cell Expansion

Expand the keratinocytes, fibroblasts, or stromal cells to clinical numbers on a defined, animal-origin-free, serum-free base.

Overview

Cell expansion grows the prepared cells to the numbers needed for the therapy. Keratinocytes, fibroblasts, and stromal cells are expanded as adherent cultures through serial passaging. Keratinocyte expansion has traditionally used a mouse fibroblast feeder layer and fetal bovine serum, both of which serum-free, feeder-free defined systems now aim to replace.

Expansion media supply a defined base of iron, carrier protein, and metabolic components, alongside the growth factors these cells require, such as EGF and FGF, which are supplied separately and are not InVitria products. Lactoferrin has also been shown to support keratinocyte and fibroblast proliferation, a role applied more directly in later repair-support steps.

A defined, animal-origin-free expansion strategy supports consistent growth and reduces the variability and animal-origin risk that serum and feeder layers introduce.

Functions

Iron Transport

Proliferating skin and stromal cells require iron for metabolism and DNA synthesis during expansion. In serum-free and defined media, transferrin delivers iron in a controlled, protein-bound form through the transferrin receptor, supporting proliferation while limiting the oxidative stress associated with free iron. Transferrin is a core component of defined media.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Serum- or plasma-derived transferrin, and serum as an iron source.

EGF Growth Signaling

Keratinocytes and dermal fibroblasts are expanded through serial passaging to reach clinical cell numbers, and EGF is the primary mitogen that drives that proliferation. Signaling through EGFR activates the ERK pathway, moving cells into the cell cycle and sustaining their doubling in serum-free, feeder-free media that no longer supply growth factors from serum or a fibroblast feeder layer. A defined, animal-origin-free EGF supplied as a sterile liquid gives consistent mitogenic input across passages, without the endotoxin, host-cell protein, and reconstitution variability that microbial or mammalian-expressed EGF introduces.

Recommendation
OptiKine™ EGF

Recombinant human Epidermal Growth Factor from an animal-origin-free expression system, for epithelial, keratinocyte, and organoid culture and stem-cell proliferation.

Commonly replaces
E. coli- or mammalian-cell-derived recombinant human EGF, bovine pituitary extract, and mouse fibroblast feeder layers used to supply mitogenic signaling in keratinocyte expansion.

Carrier & Protection

Albumin is the primary protein carrier in defined media. It binds and transports fatty acids, lipids, and metal ions, contributes antioxidant capacity, and buffers cells against handling and passaging stress. Through expansion, this carrier and protective role supports the viability and consistent growth of keratinocytes, fibroblasts, and stromal cells.

Recommendation
Optibumin® X

High-purity, 25% recombinant human serum albumin with an ultra-low fatty acid profile for stem cell (iPSC/MSC/etc.) and lipid-sensitive applications, supplied in saline with no added stabilizers.

Commonly replaces
Serum, human serum albumin (HSA), or bovine serum albumin (BSA) in expansion media.

Serum-Free Environment Support

Serum-free expansion depends on a defined metabolic base, insulin for metabolism, transferrin for iron, and selenium for oxidative balance, in place of fetal bovine serum. A blend supplies these in one addition, supporting cell proliferation while the cell-specific growth factors are supplied separately.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Fetal bovine serum (FBS) in skin and stromal cell expansion media.

Growth & Proliferation Support

Dermal fibroblasts and keratinocytes proliferate during expansion for wound repair. Lactoferrin stimulates fibroblast and keratinocyte proliferation and migration, synergizes with FGF2/EGF, and reduces apoptosis under serum-free stress.

Recommendation
Lacromin®

Recombinant human holo-lactoferrin, an iron-saturated lyophilized powder for serum-free and chemically defined cell culture media.

Commonly replaces
Bovine milk-derived lactoferrin; serum growth factors.

Optional Genetic Modification

Optionally engineer the cells to overexpress pro-healing factors, with defined, animal-origin-free components supporting cells through modification and recovery.

Overview

Genetic modification is an optional step used to enhance the cells’ repair activity. Cells, often stromal cells or fibroblasts, can be engineered to overexpress pro-healing factors such as growth factors or angiogenic proteins, improving their effect at the wound. Many wound therapies use unmodified cells and skip this step.

The factor is introduced by viral transduction or non-viral methods, performed after expansion and before the cells are built into the construct, so the modified cells populate the tissue. The vector and gene-delivery reagents are supplied separately and are not InVitria products.

Gene delivery is a stress on the cells. Maintaining a defined protein and metabolic base through modification and the recovery that follows supports viability while keeping the process animal-origin-free.

Functions

Transduction Environment Support

Gene transfer, by viral transduction or electroporation, stresses cells and is followed by a recovery window before the cells are used in the construct. Through this window, cells need a defined metabolic base, insulin, transferrin, and selenium, to support recovery and re-entry into proliferation. Maintaining this defined environment supports viability and consistent recovery after modification.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Serum and undefined supplements in transduction and recovery media.

Carrier & Protection

Through modification and recovery, albumin supports cell viability as the primary protein carrier, binding and transporting fatty acids, lipids, and metal ions, contributing antioxidant capacity, and buffering cells against the stress of gene transfer and the recovery that follows.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum, human serum albumin (HSA), or bovine serum albumin (BSA) in transduction media.

Cell / Component Washing

Wash the cells to remove spent media, enzymes, and any vector residuals before they are built into the construct, with animal-origin-free albumin.

Overview

Cell and component washing cleans the cells before they are formulated into the delivery matrix or construct. The cells are washed through buffer exchange to remove spent media, residual enzymes from earlier steps, and, where genetic modification was used, residual vector and gene-delivery reagents.

Washing exposes cells to repeated centrifugation or buffer exchange and handling. Wash buffers commonly contain albumin to protect cells and limit loss during these steps.

A defined, animal-origin-free recombinant albumin protects cells through washing while avoiding animal-derived residuals ahead of matrix preparation and construct assembly.

Functions

Cell Protection & Stabilization

During washing, cells undergo repeated buffer exchange to clear spent media, residual enzymes, and any vector residuals, which exposes them to handling and osmotic shifts. Albumin protects cells by transporting fatty acids and binding reactive species, buffering them against handling and oxidative stress and limiting loss to surfaces through the step.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum or bovine serum albumin (BSA) in cell wash buffers.

Scaffold or Delivery Matrix Preparation

Prepare the scaffold, dressing, or delivery matrix, with recombinant lactoferrin available as an antimicrobial, pro-healing matrix bioactive.

Overview

Scaffold or delivery matrix preparation builds the material that carries the cells to the wound, or that is applied with them. Wound matrices include collagen or fibrin scaffolds, chitosan, hyaluronic acid, or alginate hydrogels, and bioprinted or electrospun dressings. These base materials are selected for the wound type and are not InVitria products.

Bioactive proteins can be loaded into the matrix to act at the wound. Lactoferrin is a strong candidate: lactoferrin-loaded hydrogels and dressings combine antimicrobial activity against wound pathogens with pro-healing activity, releasing lactoferrin to support repair. Albumin is also used in matrices as a cell-compatible carrier protein.

Using defined, animal-origin-free bioactive and carrier proteins in the matrix supports consistent performance and keeps the construct free of animal-derived material.

Functions

Wound-Healing Matrix Bioactive

A wound delivery matrix can carry bioactive proteins that act directly at the wound. Lactoferrin is well suited to this role: it is antimicrobial against common wound pathogens, anti-inflammatory, and pro-healing, stimulating the proliferation and migration of keratinocytes and fibroblasts. Lactoferrin-loaded hydrogels and dressings have combined infection control with accelerated wound closure in preclinical models.

Recommendation
Lacromin®

Recombinant human holo-lactoferrin, an iron-saturated lyophilized powder for serum-free and chemically defined cell culture media.

Commonly replaces
Bovine lactoferrin used in research-grade wound dressings.

Matrix Carrier & Compatibility

Albumin is used in cell delivery matrices and dressings as a cell-compatible carrier protein. It binds and transports fatty acids, lipids, and metal ions, contributes antioxidant capacity, and conditions the matrix to support cell viability and attachment when cells are combined with the material.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum or bovine serum albumin (BSA) in cell delivery matrices.

3D Culture & Tissue Formation

Culture the cells in or on the matrix to form a skin construct or tissue, on a defined, animal-origin-free base.

Overview

3D culture and tissue formation grows the cells into a skin construct or living tissue. Fibroblasts populate the dermal layer and deposit matrix; keratinocytes are added to form an epidermis, often matured at an air-liquid interface to stratify. Scaffold-free self-assembly approaches build the construct from the cells’ own matrix.

This phase has traditionally used fetal bovine serum. Defined, serum-free media replace it with recombinant carrier protein, iron, and metabolic components, alongside the growth factors that drive skin tissue formation, such as EGF and KGF, which are supplied separately and are not InVitria products.

A defined, animal-origin-free culture strategy supports consistent tissue formation and reduces the variability that serum introduces across constructs and runs.

Functions

Iron Transport

Cells building the construct require iron for metabolism and proliferation as the tissue forms. In serum-free and defined media, transferrin delivers iron in a controlled, protein-bound form through the transferrin receptor, supporting proliferation and matrix deposition while limiting the oxidative stress associated with free iron. Transferrin is a core component of defined media.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Serum- or plasma-derived transferrin, and serum as an iron source.

EGF Growth Signaling

As keratinocytes are seeded onto the dermal layer, they must proliferate to confluence and form a continuous epidermis before stratification at the air-liquid interface. EGF drives that proliferative phase through EGFR, supporting epithelial coverage of the construct and keeping fibroblasts in the dermal compartment active while they deposit matrix. Supplying EGF as a defined, animal-origin-free component keeps the growth-factor input consistent through the days to weeks of tissue formation, so epidermal development does not vary with growth-factor lot.

Recommendation
OptiKine™ EGF

Recombinant human Epidermal Growth Factor from an animal-origin-free expression system, for epithelial, keratinocyte, and organoid culture and stem-cell proliferation.

Commonly replaces
E. coli- or mammalian-cell-derived recombinant human EGF, typically lyophilized, and serum used as a growth-factor source in skin construct culture.

Carrier & Protection

Albumin is the primary protein carrier in defined media. It binds and transports fatty acids, lipids, and metal ions, contributes antioxidant capacity, and buffers cells against handling stress through the days to weeks of tissue formation, including culture at the air-liquid interface. This supports cell viability and consistent construct development.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum, human serum albumin (HSA), or bovine serum albumin (BSA) in tissue culture media.

Serum-Free Environment Support

Serum-free tissue formation depends on a defined metabolic base, insulin for metabolism, transferrin for iron, and selenium for oxidative balance, in place of fetal bovine serum. A blend supplies these in one addition, supporting cell proliferation and matrix deposition while the growth factors are supplied separately.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Fetal bovine serum (FBS) in skin construct culture media.

Differentiation / Repair-Support Culture

Condition the construct toward an active repair phenotype, with lactoferrin supporting re-epithelialization and granulation, on a defined base.

Overview

Differentiation and repair-support culture conditions the construct so its cells take on an active, pro-healing phenotype before application. Keratinocytes stratify and mature into a functional epidermis; fibroblasts adopt a pro-healing, matrix-producing state. The goal is a construct that drives re-epithelialization, granulation, and angiogenesis at the wound.

Wound repair is driven by growth factors, such as EGF, KGF, TGF-beta, VEGF, and PDGF, which are selected for the therapy and are not InVitria products. Lactoferrin supports this repair program directly: it stimulates keratinocyte and fibroblast proliferation and migration, enhances collagen and matrix synthesis, and promotes re-epithelialization and neovascularization.

Maintaining defined, animal-origin-free conditions through this step supports a consistent repair phenotype and keeps the construct free of serum- and animal-derived material.

Functions

Re-epithelialization Signaling

Wound closure depends on keratinocytes migrating across the wound bed and proliferating behind the migrating front, and EGF is the central signal for both. EGFR activation drives keratinocyte motility, proliferation, and the production of matrix-remodeling enzymes, and EGF works with lactoferrin, which synergizes with EGF on keratinocyte and fibroblast proliferation. Conditioning the construct with a defined EGF before application primes a pro-healing phenotype, and a defined, animal-origin-free source keeps that priming consistent across lots and free of microbial and mammalian process residuals in a product headed for an open wound.

Recommendation
OptiKine™ EGF

Recombinant human Epidermal Growth Factor from an animal-origin-free expression system, for epithelial, keratinocyte, and organoid culture and stem-cell proliferation.

Commonly replaces
E. coli- or mammalian-cell-derived recombinant human EGF in repair-support and keratinocyte differentiation media.

Repair-Support Bioactive

The repair-support phase aims to maximize the construct’s pro-healing activity. Lactoferrin supports this directly across the healing cascade: it stimulates the proliferation and migration of keratinocytes and fibroblasts, enhances synthesis of extracellular matrix components such as collagen and hyaluronan, and promotes re-epithelialization and neovascularization, while adding antimicrobial and anti-inflammatory activity. Topical lactoferrin accelerates closure in normal and diabetic wounds.

Recommendation
Lacromin®

Recombinant human holo-lactoferrin, an iron-saturated lyophilized powder for serum-free and chemically defined cell culture media.

Commonly replaces
Bovine lactoferrin used in research-grade wound-healing media.

Repair-Support Environment

Through repair-support culture, the cells sit on a defined metabolic base, insulin for metabolism, transferrin for iron, and selenium for oxidative balance, that sustains them as they adopt the repair phenotype. A blend supplies these in one addition, supporting cell health while the growth factors and lactoferrin drive the repair program.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Serum and undefined supplements in repair-support media.

Carrier & Protection

Through repair-support culture, albumin continues to support cell viability as the primary protein carrier, binding and transporting fatty acids, lipids, and metal ions, contributing antioxidant capacity, and buffering cells against handling stress as the construct develops its repair phenotype.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum or bovine serum albumin (BSA) in repair-support media.

Harvest & Implant / Application Preparation

Prepare the finished construct, cell sheet, or cell suspension for application to the wound, with defined, animal-origin-free albumin stabilizing the cells.

Overview

Harvest and application preparation readies the finished product for use on the wound. Depending on the format, a skin construct or cell sheet is released from its culture vessel and trimmed, a cell suspension or spray is prepared at dosing density, or cells loaded in a matrix are packaged for application. The product is matched to how it will be delivered to the wound.

Releasing, handling, and transferring the product exposes the cells to mechanical stress and an environmental change. A stabilizing protein in the holding or application solution supports cell viability through preparation and transfer to the point of care.

A defined, animal-origin-free recombinant albumin stabilizes the product through harvest and application preparation while keeping it free of serum- and animal-derived material.

Functions

Construct Stabilization

Preparing the product for application involves release from the vessel, shaping or resuspension, and transfer into a holding or application solution, which exposes the cells to mechanical stress and an environmental change. Albumin supports cell viability through this handling by transporting fatty acids and binding reactive species, buffering cells against mechanical and oxidative stress.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum or plasma-derived albumin in product holding and application solutions.

Final Formulation & Storage

Formulate and store the finished wound product with defined, animal-origin-free recombinant albumin, supporting stability through storage and any freeze-thaw.

Overview

Final formulation and storage brings the wound product to its finished, storable form. Depending on the product, it is held refrigerated for near-term application or cryopreserved for longer storage and distribution. Cell suspensions, sheets, and matrix-loaded products are each formulated in their delivery format.

Albumin is a standard excipient in formulation and cryopreservation matrices. It stabilizes cells through storage and, for cryopreserved products, through freezing and thaw. Because this becomes the applied product, excipient safety matters: plasma-derived albumin carries adventitious-agent risk that a recombinant source removes.

A defined, animal-origin-free recombinant albumin stabilizes the formulated product through storage while keeping it free of human- and animal-derived material.

Functions

Formulation Stabilization

In final formulation and storage, the product is held in the matrix it will be stored and delivered in, which for cryopreserved products pairs a cryoprotectant such as DMSO with a protein stabilizer. Albumin is the standard stabilizer: it supports cell viability through refrigerated storage and buffers membranes against osmotic and oxidative stress through freezing and thaw. As an excipient in the applied product, its safety profile carries forward.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived human serum albumin (HSA) used as a formulation or cryopreservation excipient.